[HTML][HTML] Neural Surface Antibodies and Neurodegeneration: Clinical Commonalities and Pathophysiological Relationships

MP Giannoccaro, F Verde, L Morelli, G Rizzo… - Biomedicines, 2023 - mdpi.com
Autoimmune encephalitis and neurodegenerative disorders share several clinical features,
including behavioural and psychiatric manifestations, cognitive impairment, sleep and …

In vivo three-dimensional brain imaging with chemiluminescence probes in Alzheimer's disease models

J Zhang, C Wickizer, W Ding, R Van… - Proceedings of the …, 2023 - National Acad Sciences
Optical three-dimensional (3D) molecular imaging is highly desirable for providing precise
distribution of the target-of-interest in disease models. However, such 3D imaging is still far …

A novel method for PET connectomics guided by fibre‐tracking MRI: Application to Alzheimer's disease

Z Sun, SL Naismith, S Meikle, F Calamante… - Human Brain …, 2024 - Wiley Online Library
This study introduces a novel brain connectome matrix, track‐weighted PET connectivity
(twPC) matrix, which combines positron emission tomography (PET) and diffusion magnetic …

[HTML][HTML] Historical efforts to develop 99mTc-based amyloid plaque targeting radiotracers

G Takalloobanafshi, A Kukreja… - Frontiers in Nuclear …, 2022 - frontiersin.org
Imaging biomarkers have changed the way we study Alzheimer's disease and related
dementias, develop new therapeutics to treat the disease, and stratify patient populations in …

[PDF][PDF] Molecular Imaging of Neurodegeneration: The Way to New Horizons

VL Villemagne, H Barthel - Journal of Nuclear Medicine, 2022 - Soc Nuclear Med
Neurodegenerative disorders are chronic and progressive conditions characterized by
tissue loss in certain brain systems. They encompass most dementias, movement disorders …